BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8582114)

  • 21. Angiotensin-converting enzyme inhibition modulates mitogen-activated protein kinase family expressions in the neonatal rat kidney.
    Choi BM; Yoo KH; Bae IS; Oh MH; Hong YS; Lee JW; Kim SK
    Pediatr Res; 2005 Jan; 57(1):115-23. PubMed ID: 15531746
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of angiotensin converting enzyme inhibition, sodium depletion, calcium, isoproterenol, and angiotensin II on renin secretion by individual renocortical cells.
    Geary KM; Hunt MK; Peach MJ; Gomez RA; Carey RM
    Endocrinology; 1992 Oct; 131(4):1588-94. PubMed ID: 1396304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal responses to angiotensin receptor antagonist and angiotensin-converting enzyme inhibitor in partially nephrectomized spontaneously hypertensive rats.
    Okada H; Suzuki H; Kanno Y; Ikenaga H; Saruta T
    J Cardiovasc Pharmacol; 1995 Oct; 26(4):564-9. PubMed ID: 8569216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiotensin converting enzyme inhibition decreases cell turnover in the neonatal rat heart.
    Choi JH; Yoo KH; Cheon HW; Kim KB; Hong YS; Lee JW; Kim SK; Kim CH
    Pediatr Res; 2002 Sep; 52(3):325-32. PubMed ID: 12193663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of a stable, hypertensive rat model suitable for the consecutive evaluation of human renin inhibitors.
    St-Jacques R; Toulmond S; Auger A; Binkert C; Cromlish W; Fischli W; Harris J; Hess P; Jie Lan ; Liu S; Riendeau D; Steiner B; Percival MD
    J Renin Angiotensin Aldosterone Syst; 2011 Sep; 12(3):133-45. PubMed ID: 21393355
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of a specific endothelin receptor A antagonist and an angiotensin-converting enzyme inhibitor on glomerular mRNA levels for extracellular matrix components, metalloproteinases (MMP) and a tissue inhibitor of MMP in aminonucleoside nephrosis.
    Ebihara I; Nakamura T; Tomino Y; Koide H
    Nephrol Dial Transplant; 1997 May; 12(5):1001-6. PubMed ID: 9175058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spironolactone and enalapril differentially up-regulate the expression of VEGF and heme oxygenase-1 in the neonatal rat kidney.
    Yim HE; Kim JH; Yoo KH; Bae IS; Hong YS; Lee JW
    Pediatr Res; 2011 May; 69(5 Pt 1):378-83. PubMed ID: 21263376
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of enalapril and losartan on mechanical ventilation-induced sympathoadrenal activation and oxidative stress in rats.
    Toklu HZ; Kwon OS; Sakarya Y; Powers SK; Llinas K; Kirichenko N; Sollanek KJ; Wiggs MP; Smuder AJ; Talbert EE; Scarpace PJ; Tümer N
    J Surg Res; 2014 May; 188(2):510-6. PubMed ID: 24630519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of long-term treatment with an angiotensin-converting enzyme inhibitor on the renin-angiotensin system in spontaneously hypertensive rats.
    Morishita R; Higaki J; Okunishi H; Kawamoto T; Ishii K; Nakamura F; Katahira K; Nagano M; Mikami H; Miyazaki M
    Clin Exp Pharmacol Physiol; 1991 Oct; 18(10):685-90. PubMed ID: 1764812
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiotensin I-converting enzyme inhibition but not angiotensin II suppression alters angiotensin I-converting enzyme gene expression in vessels and epithelia.
    Costerousse O; Allegrini J; Clozel JP; Ménard J; Alhenc-Gelas F
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1180-7. PubMed ID: 9495881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discrepancy between renin mRNA and plasma renin level in angiotensin-converting enzyme inhibitor-treated rats.
    Morishita R; Higaki J; Nagano M; Nakamura F; Tomita N; Zhao Y; Mikami H; Miyazaki M; Ogihara T
    Clin Exp Pharmacol Physiol; 1993 Jan; 20(1):15-20. PubMed ID: 8381736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estrogen and enalapril attenuate the development of right ventricular hypertrophy induced by monocrotaline in ovariectomized rats.
    Ahn BH; Park HK; Cho HG; Lee HA; Lee YM; Yang EK; Lee WJ
    J Korean Med Sci; 2003 Oct; 18(5):641-8. PubMed ID: 14555814
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renin-angiotensin system involvement in pressure-overload cardiac hypertrophy in rats.
    Baker KM; Chernin MI; Wixson SK; Aceto JF
    Am J Physiol; 1990 Aug; 259(2 Pt 2):H324-32. PubMed ID: 2143633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor necrosis factor-alpha gene expression in diabetic nephropathy: relationship with urinary albumin excretion and effect of angiotensin-converting enzyme inhibition.
    Navarro JF; Milena FJ; Mora C; León C; Claverie F; Flores C; García J
    Kidney Int Suppl; 2005 Dec; (99):S98-102. PubMed ID: 16336586
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of angiotensin-converting enzyme inhibition on growth factor mRNA in chronic renal allograft rejection in the rat.
    Szabo A; Lutz J; Schleimer K; Antus B; Hamar P; Philipp T; Heemann U
    Kidney Int; 2000 Mar; 57(3):982-91. PubMed ID: 10720951
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ACE inhibition increases expression of the ETB receptor in kidneys of mice with unilateral obstruction.
    Moridaira K; Morrissey J; Fitzgerald M; Guo G; McCracken R; Tolley T; Klahr S
    Am J Physiol Renal Physiol; 2003 Jan; 284(1):F209-17. PubMed ID: 12473537
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Additive effects of enalapril and losartan in (mREN-2)27 transgenic rats.
    Richer C; Bruneval P; Ménard J; Giudicelli JF
    Hypertension; 1998 Feb; 31(2):692-8. PubMed ID: 9461242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of plasminogen activator inhibitor-1 in vivo: a new mechanism for the anti-fibrotic effect of renin-angiotensin inhibition.
    Oikawa T; Freeman M; Lo W; Vaughan DE; Fogo A
    Kidney Int; 1997 Jan; 51(1):164-72. PubMed ID: 8995730
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High salt intake and the brain renin--angiotensin system in Dahl salt-sensitive rats.
    Zhao X; White R; Huang BS; Van Huysse J; Leenen FH
    J Hypertens; 2001 Jan; 19(1):89-98. PubMed ID: 11204309
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A selective cyclooxygenase-2 inhibitor decreases proteinuria and retards progressive renal injury in rats.
    Wang JL; Cheng HF; Shappell S; Harris RC
    Kidney Int; 2000 Jun; 57(6):2334-42. PubMed ID: 10844603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.